Consumption of coffee, a popular beverage worldwide, has been associated with lower colorectal cancer (CRC) risk. Although CRC exhibits different biological characteristics by anatomical subsite, the possibly heterogeneous impact of coffee on CRC by anatomical subsite has remained unclear. Here, we conducted two case-control studies to examine the association between coffee consumption and CRC risk as well as risk by anatomic subsite among Japanese using data from the Hospital-based Epidemiological Research Program at Aichi Cancer Center I and II (HERPACC-I and II). Subjects were enrolled in HERPACC-I between 1988 and 2000 and in HERPACC-II between 2001. Coffee consumption was measured with a selfadministered questionnaire. A conditional logistic regression model was used to calculate odds ratios (ORs) of CRC with coffee consumption, adjusted for potential confounders of age, smoking, alcohol drinking, red meat intake, BMI, exercise, family history of CRC, and diabetes mellitus history. We estimated summary ORs by pooling study-specific ORs with a fixed effects model. In total, 2,696 CRC cases and 13,480 non-cancer outpatients as controls were included. Overall, compared to nondrinkers, ORs of less than 1 cup/day, 1-2 cups/day and 3 or more cups/day for CRC were 0.88 (95% CI: 0.77-1.00), 0.90 (95% CI: 0.80-1.01) and 0.78 (95% CI: 0.65-0.92), respectively (trend-p 5 0.009). Subsite-specific analysis revealed a significant inverse linear trend between coffee consumption and distal colon cancer (p-trend 5 0.048), and a tendency toward a lower risk of rectal cancer (p-trend 5 0.068). These findings suggest that coffee consumption might impact the prevention of CRC, especially distal colon cancer.
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Incidence shows considerable geographical variation, however, and almost 55% of cases occur in more developed regions. In Japan, incidence and mortality rates of CRC have increased markedly over the last several decades, 1,2 with an age-standardized incidence rate to world population per 100,000 of 16.8 (males) and 12.9 (females) 3 in 1975 rising to 63.5 and 37.2, 4 respectively, by the mid-1990s. This increase might be associated with changes in environmental factors, including dietary factors and lifestyle. 2 Among dietary factors, red meat, processed meat and substantial consumption of alcoholic drinks (in men) are judged as convincing risk factors, while the only convincing protective factors are foods containing dietary fibre. 5, 6 The role of coffee, a popular beverage worldwide, in human health has received substantial attention. 7 Recently, the International Agency for Research on Cancer (IARC) concluded that evidence supported a role of coffee consumption in reducing the risk of cancers of the liver and uterine endometrium. 8 A number of epidemiological studies have discussed the relationship between coffee consumption and colorectal cancer risk. A meta-analysis of 13 case-control studies and a large prospective study reported that coffee intake might be protective against colorectal cancer. 9,10 However, the World Cancer Research Fund and American Institute of Cancer Research reported that the evidence for coffee remains limited and non-conclusive. 11 In Japan, the most popular types of coffee are instant coffee, brewed coffee, and canned coffee, the latter being a Japanese innovation which is already brewed and ready to drink. 12 Although coffee consumption in Japan is relatively low compared to intake in Western settings, where mean per capita consumption was variously around 16-24 cups/week in 2014, [12] [13] [14] coffee drinking is increasingly popular in Japan, with mean per capita consumption of 11 cups/week in 2014. 12 Therefore, it would be interesting to know whether coffee consumption is associated with risk of colorectal cancer. Previous case-control [15] [16] [17] [18] [19] and prospective studies [20] [21] [22] [23] of colorectal cancer in Japanese populations have shown controversial and inconsistent results with considerable heterogeneity. The National Cancer Center's Development and Evaluation of Cancer Prevention Strategies in Japan 24 report and a recent meta-analysis both reported that the evidence level for an effect of coffee on colorectal cancer is insufficient. 25 Overall, conclusive evidence to prove a protective effect of coffee against colorectal cancer risk is still lacking.
Furthermore, the clinical and biological characteristics of colorectal cancer differ among different anatomical subsites of the colorectum. 26, 27 Epidemiological studies have suggested that the impact of risk factors on colorectal cancer, such as low physical activity, aspirin use, and meat components, might differ by anatomical subsite. [28] [29] [30] [31] These findings have lead to further hypotheses about potential variation in the effect of coffee on colorectal cancer by anatomic subsite, which is the main purpose in this study. Nevertheless, only a very few studies have investigated this association by subsite. 16, 23, 32 Here, we conducted a meta-analysis of two large casecontrol studies in Japanese to evaluate the association between the consumption of coffee and risk of colorectal cancer by anatomic subsite.
Material and Methods
The Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC) was launched in 1988 via a questionnaire survey completed by first-visit outpatients at the Aichi Cancer Center Hospital, Nagoya, Japan. Details of HERPACC have been described elsewhere. 33, 34 All patients were asked at first visit about their lifestyle when they were healthy or before their current symptoms developed. Subjects were enrolled in HERPACC-I between 1988 and 2000, and in HERPACC-II between 2001 and 2005. HERPACC-II was started in 2001, with all first-visit outpatients asked to provide 7 ml blood and more detailed information on lifestyle in a questionnaire. All subjects were asked about the average frequency and amount of foods consumed and dietary habits during the 1 year preceding the interview or the onset of the present disease. A trained interviewer checked a selfadministered questionnaire at collection. The data were loaded into the computer system of the Aichi Cancer Center Research Institute and linked with the hospital-based cancer registry files to match the data on cancer incidence. We previously confirmed that the lifestyle patterns of first-visit outpatients without cancer were equivalent to those of a general population of subjects randomly selected from Nagoya in Japan to confirm the external validity of the study, in both HERPACC-I 35 and HERPACC-II (unpublished data). Informed consent was obtained from all participants at enrollment, and the studies were approved by the Ethical Committee of Aichi Cancer Center Institute.
Cases and controls
A total of 1,867 and 829 colorectal cancer patients (ICD-10 th , C18-C20) were recruited as case subjects in HERPACC-I and HERPACC-II, respectively. Controls were 9,335 and 4,145 first-visit outpatients independently selected from non-cancer patients in HERPACC-I and HERPACC-II, respectively, with sex-and age-matching (6 5 years) and an overall casecontrol ratio of 1:5 to maximize statistical power. Cases were divided into two groups, colon cancer, (C18.0-18.8) and rectal cancer, (C19.9-C20.9) for stratified analysis by anatomical subsite. Colon cancer patients, not otherwise specified (C18.9) were excluded from this categorization (408 cases in HERPACC-I and 50 cases in HERPACC-II) on the basis that rectal cancer may be included in this category and we did not distinguish rectal cancer coded to C18.9. Colon cancer patients were further categorized into two groups, those with proximal colon cancer (cecum, appendix, ascending colon and hepatic flexure of the colon; C18.0-18.5) and distal colon cancer (descending colon and sigmoid colon; C18.6-C18.7 
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Exposure measurement
The questionnaire for the HERPACC-I and -II studies included questions on occupation, medical history (such as history of diabetes mellitus), height, weight, family history (first degree relatives, i.e., parents, and siblings), smoking and drinking habits, dietary habits, sleeping habits, physical exercise and reproductive history. All exposures were measured with a self-administered questionnaire given at the time of the first visit to the hospital and before any diagnostic procedures were conducted. Information on coffee was obtained in terms of frequency and intake [every day (number of cups/day), occasionally, never] in HERPACC-I and (never, 1-3 cups/month, 1-2 cups/ week, 3-4 cups/week, 5-6 cups/week, 1 cup/day, 2 cups/day, 3 cups/day) in HERPACC-II. Smoking status was entered under the four categories of never, former, and current smoking of 10 cigarettes/day or >10 cigarettes/day. Former smokers were defined as those who had quit smoking at least 1 year before the survey. Total alcohol consumption was estimated as the summed amount of pure alcohol consumption. Alcohol drinking habits were entered in the four categories of none, current moderate, moderate-heavy and heavy drinking. Moderate drinkers were defined as those currently consuming less frequently than 4 days per week in HERPACC-I and less frequently than 5 days per week in HERAPCC-II; moderateheavy drinkers as those currently consuming on 4 days or more per week in HERPACC-I and 5 days or more per week in HERAPCC-II at a daily amount of up to 23 g (1 Japanese drink); and heavy drinkers as those currently consuming on 4 days or more per week in HERPACC-I and 5 days or more per week in HERAPCC-II at a daily amount of 23 g or more. Red meat intake was entered in the two categories of low and high intake, with high intake defined as eating red meat 3 times or more per week in both studies. Exercise frequencies were entered in the four categories of none, occasional, often and very often in HERPACC-I, and in the five categories of none, occasional, often, very often and almost everyday in HERPACC-II. In HERPACC-I, occasional exercise was defined as exercising 2 times or less per month, often as 3-4 times per month, and very often as 2 times or more per week; and in HERPACC-II, occasional exercise was defined as exercising 1-3 times per month, often as 1-2 times per week, very often as 3-4 times per week, and almost everyday as 5 times or more per week. Information on a history of diabetes was obtained as yes or no. Family history of colorectal cancer in a 1st degree relative was obtained as yes or no. These factors were measured using a self-administered questionnaire, with responses checked by trained interviewers.
Statistical analysis
Conditional logistic regression was used to obtain odds ratios (ORs) and 95% conditional intervals (95%CIs) as a measure of association. The subjects were categorized based on coffee consumption into the four groups of none, <1 cup/day, 1-2 cups/day, and 3 or more cups/day and included in the models using the none group as reference. The dose-response relationship was examined by models in which the nondrinking group to the 3 or more cups/day group were respectively scored as 0, 1, 2, and 3, as explanatory variables in individual studies. Models included the potential confounders of age (continuous), sex, smoking status, alcohol drinking habit, red meat intake, BMI (<18.5, 18.5-<20, 20-<22.5, 22.5-<25, 25-<27.5, 27.5), exercise, family history of colorectal cancer, and diabetes mellitus history. Given the differences in questionnaire items and definition between HERPACC-I and -II, we estimated summary ORs by pooling study-specific ORs from HERPACC-I and HERPACC-II for categories of coffee intake. We tested heterogeneity among studies for each category using Cochran's Q statistics and the I 2 statistic. 36 Cases of statistically significant heterogeneity were dealt with using a random-effects model. Otherwise, we applied a fixed effects model. We used forest plots to describe summary ORs and those from HERPACC-I and HERPACC-II separately. We statistically tested the difference in colorectal cancer risk associated with coffee consumption between smoking status (never or ever) or age groups (age < 60 or age 60 years old) by including an interaction term into the regression model. All analyses were performed with Stata v. 14.1 (STATA Corporation, College Station, TX).
Results

Study population
A total of 2,696 colorectal cancer cases and 13,480 noncancer controls were included in this study. Table 1 shows the distribution of selected demographic and lifestyle factors for cases and controls. In both the HERPAC-I and -II studies, colorectal cancer cases were more likely to have had a family history of colorectal cancer, a higher prevalence of diabetes, and less physical activity than the controls.
Colorectal cancer risk and coffee intake
ORs for the association of coffee consumption with the risk of colorectal cancer from each study individually are shown in Table 2, Supporting information Tables 1 and 2 , and the forest plots in Figure 1a . We observed significant inverse associations of colorectal cancer with coffee intake in the HERPACC-I study: the ORs for individuals who consumed <1 cup/day, 1-2 cups/day and >3 cups/day were 0.86 (0.73-1.00), 0.89 (0.78-1.01) and 0.75 (0.61-0.91), with statistical significance for the trend (p 5 0.009; Table 2 ). Results of the HERPACC-II study was consistent with those of the HERPACC-I study, and the point estimates for the effect measures were in same direction, with ORs of <1.0 even though the association was not statistically significant in the HERPACC-II study. Table 2 and the forest plots in Figure 1a show summary estimates for the association of coffee consumption with the risk of colorectal cancer from the two studies. As no heterogeneity was found, we used a fixed effects model. We observed significant inverse associations of Table 1 . Distribution of selected demographic and lifestyle factors by case and control according to the HERPACC-I and -II studies 
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colorectal cancer with coffee intake: summary ORs for individuals who consumed <1 cup/day, 1-2 cups/day and >3 cups/ day were 0.88 (0.77-1.00), 0.90 (0.80-1.01) and 0.78 (0.65-0.92), with statistical significance for the trend (p 5 0.009). Summary estimates for the association also showed consistent results by sex for the total study (Table 3 ) and in estimates for the two studies separately (Tables 2 and 3 ). Supporting information Table 3 shows odds ratios and 95% confidence intervals for colorectal cancer with interaction among smoking habit and age groups. The effect of coffee consumption on colorectal cancer risk was not modified by smoking habits: p for interaction was 0.93 and 0.61 in the HERPACC1 and 2 studies, respectively. The interaction between the coffee consumption and age groups was not significant in either HERPACC-I (p 5 0.90) or HERPACC-II (p 5 0.67).
Colorectal cancer risk and coffee intake by anatomical subsite Table 2 and Figures 1be (Fig. 1b, colon cancer; Fig. 1c , proximal colon; Fig. 1d , distal colon; and Fig. 1e , rectal cancer) show summery estimates for the association of coffee consumption with the risk of colorectal cancer by cancer subsite from the two studies.
As no heterogeneity was found between the two studies, we used a fixed effects model. The risk of distal colon cancer showed a significant inverse association with coffee intake, with summary ORs for individuals consuming <1 cup/day, 1-2 cups/day and >3 cups/day of 0.80 (95% CI: 0.62-1.04), 0.78 (0.62-0.98) and 0.76 (0.55-1.07), respectively, with statistically significance for the trend (p for trend, 0.048). We also observed a marginally significant association between coffee intake and lower risk of rectal cancer (p for trend, 0.068), with the correspondent summary ORs of 0.99 (95% CI: 0.80-1.22), 0.94 (0.78-1.13) and 0.75 (0.58-0.98), respectively. In contrast, there was no significant inverse association for proximal colon cancer. The results by subsite were consistent when stratified by sex (Table 4) . Moreover, when analysed separately, results of the two studies were consistent by subsite (Figs. 1b-e and Table 2 ), and also by subsite when stratified by sex (Table 4) .
Discussion
In this study, we showed that coffee intake was inversely associated with the risk of colorectal cancer. In subsite-specific analysis, we revealed an association with a lower risk for distal colon cancer, and a possibly lower risk for rectal cancer. In contrast, we saw no clear association with proximal colon cancer risk. To our knowledge, this is the largest study to show a difference in the impact of coffee intake by subsite of colorectal cancer in a Japanese or Asian population.
Several possible mechanisms support an inverse association of coffee intake with colorectal cancer. First, coffee contains several antioxidant and antimutagenic components with potential anticarcinogenic activities in animal models and cell culture systems. 37 These include phenolic compounds (such as chlorogenic and caffeic acids), melanoidins and diterpenes (such as cafestol and kahweol). 37, 38 In particular, cafestol and kahweol might reduce the genotoxicity of several carcinogens. 37 Second, bile acids have been reported to act as tumor promoters in the colon, 39, 40 and coffee induces a reduction in bile acid secretion because cafestol down-regulates expression of the bile acid homeostatic genes. 41, 42 Furthermore, diabetes type 2 is a risk factor for colorectal cancer. 43 Chlorogenic acid, a component of coffee, was reported to reduce glucose absorption in the intestine by inhibiting glucose-6-phosphate translocase. 44 Finally, coffee might reduce colorectal cancer risk by increasing colonic motility. 45 These mechanisms may 
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Association between coffee consumption and colorectal cancer support an association of coffee intake with a lower colorectal cancer risk. Moreover, possible mechanisms behind these subsite differences in the impact of coffee consumption warrant discussion. A previous study found that the increase in colon motility by coffee was greatest in the distal colon 45 Moreover, dysbiosis changes in bacterial composition of the gut microbiota have been reported to influence the risk of colorectal carcinogenesis, and a recent study revealed that a coffee component, chlorogenic acid, significantly increased microbiotal growth in the distal region of the colon. 46 Subsites within the colorectum have distinct embryonic origins. Differences in the development and biology of the proximal and distal colon might be reflected in differing susceptibility to neoplastic transformation, which might arise through different pathogenic mechanisms. 47 These differences might affect susceptibility to environmental risk factors, and could lead to subsite differences in the impact of coffee consumption on risk factors for colorectal cancer. Further studies are required to elucidate the mechanisms of coffee consumption on the heterogeneity of effect by anatomical sub-site.
Among previous studies of the association of coffee intake with the risk of colorectal cancer, a meta-analysis of casecontrol studies found a significant inverse association between intake and colorectal cancer risk. 10 A recent large prospective study, the NIH-AARP Diet and Health Study, showed a decreased risk for colon cancer in those who drank >4 cups of coffee/day. 9 In other Asian countries, only a few studies have examined the influence of coffee intake on the risk of colorectal cancer. 48, 49 In Japan, several cohort and case-control studies have appeared. A recent meta-analysis among Japanese reported that case-control studies showed a significantly lower risk of colorectal or colon cancer, but this was unclear in cohort studies. 25 A possible reason is that the associations in case-control studies might seem stronger than those in cohort studies because findings from case-control studies could be interpreted with caution. The paper mentioned that patients with colorectal cancer might tend to underreport past coffee consumption as a result of decreased dietary intake after cancer diagnosis. 25 Our present results for colorectal cancer overall are consistent with these previous studies, and with the hypothesized mechanisms. The heterogeneous impact of coffee intake by subsite remains inconsistent: while we report here an inverse association between coffee intake and distal colon and possibly rectal cancer, other studies have reported an inverse association for distal colon but not proximal colon cancer risk. 16, 32 Further studies to specifically address this question in view of these hypothesized mechanisms are warranted. Our study has shown different directions of association by proximal and distal subsite in males and females, particularly in the category of 3 cups/day, albeit that this difference might have been due to the small sample size, especially in women (Table 4) .
Our study has several strengths and limitations. Methodological strengths include the largest number of cases and controls among case-control studies to date in both Japan as well as Asian countries in clarifying the association between coffee consumption and colorectal cancer risk. Second, age and sex were closely controlled by matching in both studies, and each study adjusted for potential confounders. Finally, our sample 
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Senda Nakagawa et al. sized allowed us to conduct subsite-specific analyses, which only a few other studies have investigated. Among limitations, the study used a hospital-based case control design, and might therefore have a degree of selection bias. However, the control group was composed of noncancer patients who enrolled in the HERPACC-I/II studies at Aichi Cancer Center Hospital and who will likely visit Aichi Cancer Center if they do develop cancer. This means that the control population was selected from the same population base as our cases, thus warranting the internal validity of the study. Further, our previous validation studies for HERPACC-I 35 and -II confirmed that our control population had similar characteristics to the general population of Nagoya [unpublished data], warranting the external validity of this study. Second, recall bias is unavoidable in casecontrol studies. We collected the lifestyle factor information before the subjects were diagnosed with cancer, and were able to keep recall bias low between cases and control group. Furthermore, because our study period was 1988-2005, the effect of coffee consumption on the risk of colorectal cancer was not well known among the public, and recall bias might be low. Third, findings from case-control studies should be interpreted with caution. We minimized this limitation by asking all patients about their lifestyle when they were healthy or before their current symptoms developed. Finally, we did not collect details of coffee consumption, such as cup size, use of caffeinated or decaffeinated coffee, type of coffee (espresso, drip, canned and so on), or method of preparation (filtered or boiled). Brewed coffee is made by brewing ground coffee beans with hot water. Brewing in Japan is most commonly done by drip or filter, and less commonly under pressure with an espresso machine. In addition, decaffeinated coffee and boiled coffee are very uncommon in Japan, 12 and it was considered that assessment of the use and methods of coffee intake, and evaluation of their effects among Japanese would be uninformative. In fact, coffee consumption in Japan is relatively low compared to intake in Western countries. 12, 14 This lower intake notwithstanding, we were able to demonstrate an inverse association between coffee intake and risk of colorectal cancer, with evidence of a dose-response relationship. In summary, this meta-analysis of data from two casecontrol studies of a Japanese population showed that coffee consumption was associated with a lower risk of colorectal cancer in a consumption-dependent manner; and was particularly associated with a lower risk of distal colon cancer, and possibly with a lower risk of rectal cancer. This finding suggested that consumption of coffee is likely to have an impact on colorectal cancer prevention. However, given the limited evidence for an association between coffee consumption and a substantial impact on colorectal cancer prevention and the inherent limitations of our study, verification of these findings awaits further studies, especially prospective cohort studies.
